Search
Search Results
##search.searchResults.foundPlural##
-
SIMPLE PERIPHERAL BLOOD SMEAR FINDINGS OF COVID-19 PATIENTS PROVIDE INFORMATION ABOUT THE SEVERITY OF THE DISEASE AND THE DURATION OF HOSPITAL STAY. Peripheral blood smear and COVID-19 severity.
3498PDF: 1212HTML: 499 -
THERAPY-RELATED MYELOID MALIGNANCIES IN MYELOMA
2537PDF: 811HTML: 1743 -
Acquired Sideroblastic Anemia: An exploratory Comparative Statistical Analysis Between Clonal and Non-clonal cases Acquired Sideroblastic Anemia
1144PDF: 666HTML: 468 -
Routine inflammatory markers are elevated in myelodysplastic syndromes at presentation Inflammatory marker elevation in MDS
925PDF: 702HTML: 251 -
THERAPY-RELATED MYELOID NEOPLASM IN NON-HODGKIN LYMPHOMA SURVIVORS
2713PDF: 781HTML: 2320 -
MOLECULAR PATHOGENESIS OF SECONDARY ACUTE PROMYELOCYTIC LEUKEMIA
2945PDF: 886HTML: 6602Untitled: 257Untitled: 211Untitled: 232Untitled: 242 -
LYON-UNIVERSITY HOSPITAL EXPERIENCE WITH GEMTUZUMAB OZOGAMICIN THERAPY IN ACUTE MYELOID LEUKEMIA: A ‘REAL-LIFE’ STUDY Gemtuzumab ozogamicin in AML
1934PDF: 1193HTML: 336 -
THERAPY-RELATED MYELOID NEOPLASMS: CONSIDERATIONS FOR PATIENTS’ CLINICAL EVALUATION. Clinical Evaluation of T-AML
1949PDF: 855HTML: 252 -
THE CHALLENGE OF AML IN OLDER PATIENTS
2338PDF: 1009HTML: 2223 -
-
Complex and Multifaceted Therapy-Related Myeloid Neoplasm Following Laryngeal Cancer Treated with Cisplatin and Radiotherapy
1230PDF: 783HTML: 1527Figure 1: 214Figure 2: 206 -
Idiopathic pulmonary embolism in a case of severe family ANKRD26 thrombocytopenia
2308PDF: 859HTML: 965Patient’s family tree: 195 -
GILTERITINIB (XOSPATA ®) IN TURKEY: EARLY ACCESS PROGRAM RESULTS Gilteritinib (XOSPATA ®) in Turkey
1517PDF: 938Suppl. Files: 467HTML: 293 -
SIMILARITIES OF ELDERLY AND THERAPY-RELATED AML
3757PDF: 924HTML: 6863 -
INVASIVE FUNGAL INFECTION IN CHILDREN WITH ACUTE LEUKEMIA AND SEVERE APLASTIC ANEMIA IFI in Children with Acute Leukemia and SAA
2835PDF: 930HTML: 291 -
Status Epilepticus Due to Severe HHV-6 Encephalitis in an Allogeneic Stem Cell Transplant Recipient
1226PDF: 857HTML: 2191Figue 1: 189 -
TREATMENT OF INDOLENT AND ADVANCED SYSTEMIC MASTOCYTOSIS Systemic Mastocytosis Treatment
2195PDF: 1595HTML: 658 -
The diagnostic sensitivity of beta-D-glucan assay in patients with chronic disseminated candidiasis
1349PDF: 1129PDF: 912HTML: 189 -
DNA Repair Genes and Chronic Myeloid Leukemia: XPD (751), XRCC1 (399), XRCC4-Intron 3, XRCC4 (1394) Gene Polymorphisms Polymorphisms of DNA Repair Genes in CML
1159PDF: 466HTML: 276 -
TRANSCRIPTOME ANALYSIS OF BETA-CATENIN-RELATED GENES IN CD34+ HAEMATOPOIETIC STEM AND PROGENITOR CELLS FROM PATIENTS WITH AML Transcriptome analysis of beta-catenin-related genes in AML
1123PDF: 1209Suppl. Files: 584HTML: 95 -
EVALUATION OF USING EMPIRIC GLYCOPEPTIDES IN ACCORDANCE WITH THE IDSA GUIDELINE IN HEMATOLOGIC MALIGNANCY PATIENTS WITH FEBRILE NEUTROPENIA Empiric glycopeptide use in neutropenic fever
1579PDF: 1129HTML: 261







